Understanding molecular mechanisms subserving control of glutamate and glutamine production and utilization in brain and peripheral organs is of crucial importance because these amino acids serve many vital functions in neurons and glial cells. Glutamate is an excitatory neurotransmitter and at higher concentrations is toxic to the brain. Glutamine functions as: (i) a precursor of glutamate, gamma aminobutyric acid, purines and pyrimidines, (ii) a protein constituent, (iii) respiratory fuel, and (iv) detoxification product of ammonia. Glutamine production and utilization are dynamically coupled to glutamate. Glutamate is compartmentalized, most likely because of the localization of glutamine synthetase and glutaminase in specific cell constituents and cell types. Compartmentation adds an additional level ot complexity to the control of glutamine and glutamate metabolism in the brain. Our research will focus on (i) the transcriptional control of glutamine synthetase and glutaminase, (ii) the post-transcriptional control of these enzymes by intracellular effectors, and (iii) compartmentation of glutamate and its effect on glutamate and glutamine metabolism in brain. The objective of the proposed studies is to increase our knowledge of these mechanisms via detailed and comprehensive investigations into the control of gene expression and intracellular regulation of glutamine synthetase (the enzyme that synthesizes glutamine), and glutaminase (the enzyme that converts glutamine to glutamate), and glutamate decarboxylase. The expression of these enzymes appears to be controlled by a multiplicity of effectors, including substrate and product (glutamine inhibits while glutamate stimulates glutamine synthetase, whereas glutamate inhibits and glutamine stimulates glutaminase), glucocorticoids, and cyclic AMP. These multiple modes of control of glutamine synthetase and degradation afford great flexibility in regulating the production and utilization of these vital amino acids. An important objective of our studies is to understand the integration of these various influences on the expression of glutamine synthetase and glutaminase. Alterations of any of these regulatory mechanisms could lead to neurological dysfunction. Abnormalities of glutamate function have been implicated in neurodegenerative disorders such as olivopontocerebellar degeneration, epilepsy, and neurotoxicity during ischemia. Therefore, the proposed studies will emphasize the close relationship of glutamine and glutamate and their relation to abnormal brain function. A major advantage of the proposed studies Is the combination of cellular and molecular biological approaches to this important problem.

Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Type
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Jaber, Sausan M; Bordt, Evan A; Bhatt, Niraj M et al. (2018) Sex differences in the mitochondrial bioenergetics of astrocytes but not microglia at a physiologically relevant brain oxygen tension. Neurochem Int 117:82-90
Ferreira, Gustavo C; McKenna, Mary C (2017) L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain. Neurochem Res 42:1661-1675
Tang, Shiyu; Xu, Su; Lu, Xin et al. (2016) Neuroprotective Effects of Acetyl-L-Carnitine on Neonatal Hypoxia Ischemia-Induced Brain Injury in Rats. Dev Neurosci 38:384-396
Demarest, Tyler G; Schuh, Rosemary A; Waddell, Jaylyn et al. (2016) Sex-dependent mitochondrial respiratory impairment and oxidative stress in a rat model of neonatal hypoxic-ischemic encephalopathy. J Neurochem 137:714-29
Waddell, Jaylyn; Hanscom, Marie; Shalon Edwards, N et al. (2016) Sex differences in cell genesis, hippocampal volume and behavioral outcomes in a rat model of neonatal HI. Exp Neurol 275 Pt 2:285-95
Xu, Su; Waddell, Jaylyn; Zhu, Wenjun et al. (2015) In vivo longitudinal proton magnetic resonance spectroscopy on neonatal hypoxic-ischemic rat brain injury: Neuroprotective effects of acetyl-L-carnitine. Magn Reson Med 74:1530-42
Pershing, Michelle L; Bortz, David M; Pocivavsek, Ana et al. (2015) Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia. Neuropharmacology 90:33-41
McKenna, Mary C; Scafidi, Susanna; Robertson, Courtney L (2015) Metabolic Alterations in Developing Brain After Injury: Knowns and Unknowns. Neurochem Res 40:2527-43
Choe, Moran; Brusgard, Jessica L; Chumsri, Saranya et al. (2015) The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells. J Cell Biochem 116:2210-26
Roelofs, Brian A; Ge, Shealinna X; Studlack, Paige E et al. (2015) Low micromolar concentrations of the superoxide probe MitoSOX uncouple neural mitochondria and inhibit complex IV. Free Radic Biol Med 86:250-8

Showing the most recent 10 out of 176 publications